BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 11865059)

  • 21. Crystal structure of the BTB domain from PLZF.
    Ahmad KF; Engel CK; Privé GG
    Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12123-8. PubMed ID: 9770450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein.
    David G; Alland L; Hong SH; Wong CW; DePinho RA; Dejean A
    Oncogene; 1998 May; 16(19):2549-56. PubMed ID: 9627120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF.
    Dhordain P; Albagli O; Honore N; Guidez F; Lantoine D; Schmid M; The HD; Zelent A; Koken MH
    Oncogene; 2000 Dec; 19(54):6240-50. PubMed ID: 11175338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways.
    Dong S; Tweardy DJ
    Blood; 2002 Apr; 99(8):2637-46. PubMed ID: 11929748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-stream regions of the POZ-domain influence the interaction of the t(11;17)-associated PLZF/RARalpha fusion protein with the histone-deacetylase recruiting co-repressor complex.
    Puccetti E; Sennewald B; Fosca-Ferrara F; Boehrer S; Bianchini A; Hoelzer D; Ottmann OG; Nervi C; Ruthardt M
    Hematol J; 2001; 2(6):385-92. PubMed ID: 11920278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain.
    Ahmad KF; Melnick A; Lax S; Bouchard D; Liu J; Kiang CL; Mayer S; Takahashi S; Licht JD; Privé GG
    Mol Cell; 2003 Dec; 12(6):1551-64. PubMed ID: 14690607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein.
    Guidez F; Howell L; Isalan M; Cebrat M; Alani RM; Ivins S; Hormaeche I; McConnell MJ; Pierce S; Cole PA; Licht J; Zelent A
    Mol Cell Biol; 2005 Jul; 25(13):5552-66. PubMed ID: 15964811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple regions of ETO cooperate in transcriptional repression.
    Hildebrand D; Tiefenbach J; Heinzel T; Grez M; Maurer AB
    J Biol Chem; 2001 Mar; 276(13):9889-95. PubMed ID: 11150306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The nuclear receptor co-repressor (N-CoR) utilizes repression domains I and III for interaction and co-repression with ETO.
    Lausen J; Cho S; Liu S; Werner MH
    J Biol Chem; 2004 Nov; 279(47):49281-8. PubMed ID: 15377655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of receptor interaction and transcriptional repression by the corepressor SMRT.
    Li H; Leo C; Schroen DJ; Chen JD
    Mol Endocrinol; 1997 Dec; 11(13):2025-37. PubMed ID: 9415406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promyelocytic leukemia zinc finger-retinoic acid receptor α (PLZF-RARα), an oncogenic transcriptional repressor of cyclin-dependent kinase inhibitor 1A (p21WAF/CDKN1A) and tumor protein p53 (TP53) genes.
    Choi WI; Yoon JH; Kim MY; Koh DI; Licht JD; Kim K; Hur MW
    J Biol Chem; 2014 Jul; 289(27):18641-56. PubMed ID: 24821728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Flt3 internal tandem duplication mutant inhibits the function of transcriptional repressors by blocking interactions with SMRT.
    Takahashi S; McConnell MJ; Harigae H; Kaku M; Sasaki T; Melnick AM; Licht JD
    Blood; 2004 Jun; 103(12):4650-8. PubMed ID: 14982881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insights into strand exchange in BTB domain dimers from the crystal structures of FAZF and Miz1.
    Stogios PJ; Cuesta-Seijo JA; Chen L; Pomroy NC; Privé GG
    J Mol Biol; 2010 Jul; 400(5):983-97. PubMed ID: 20493880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein.
    Xia ZB; Anderson M; Diaz MO; Zeleznik-Le NJ
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8342-7. PubMed ID: 12829790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modification of promyelocytic leukemia zinc finger protein (PLZF) by SUMO-1 conjugation regulates its transcriptional repressor activity.
    Kang SI; Chang WJ; Cho SG; Kim IY
    J Biol Chem; 2003 Dec; 278(51):51479-83. PubMed ID: 14527952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oligomerization of ETO is obligatory for corepressor interaction.
    Zhang J; Hug BA; Huang EY; Chen CW; Gelmetti V; Maccarana M; Minucci S; Pelicci PG; Lazar MA
    Mol Cell Biol; 2001 Jan; 21(1):156-63. PubMed ID: 11113190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of FAZF as a novel BMP2-induced transcription factor during osteoblastic differentiation.
    Ikeda R; Yoshida K; Inoue I
    J Cell Biochem; 2007 May; 101(1):147-54. PubMed ID: 17171645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The corepressor N-CoR and its variants RIP13a and RIP13Delta1 directly interact with the basal transcription factors TFIIB, TAFII32 and TAFII70.
    Muscat GE; Burke LJ; Downes M
    Nucleic Acids Res; 1998 Jun; 26(12):2899-907. PubMed ID: 9611234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of PML and PML-RARalpha in Mad-mediated transcriptional repression.
    Khan MM; Nomura T; Kim H; Kaul SC; Wadhwa R; Shinagawa T; Ichikawa-Iwata E; Zhong S; Pandolfi PP; Ishii S
    Mol Cell; 2001 Jun; 7(6):1233-43. PubMed ID: 11430826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sequence-specific DNA binding and transcriptional regulation by the promyelocytic leukemia zinc finger protein.
    Li JY; English MA; Ball HJ; Yeyati PL; Waxman S; Licht JD
    J Biol Chem; 1997 Sep; 272(36):22447-55. PubMed ID: 9278395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.